MarketPeel
Insider Trading Intelligence
Pricing
…
AG

Abizer Gaslightwala

AKTX
CEO · AKARI THERAPEUTICS PLC · CIK 0002049375
FILING MIX · LIFETIME100%/0%
BUYS
26
SELLS
0
TOTAL VALUE
$1.09M
COMPANIES
1
ACTIVE SINCE
Dec 2024
HOLDINGS NOW
5,500
AVG SELL PX
—
TRADE KIND
SHOWING 26 / 26
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
11 backtested trades · 8 horizons · 18 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Abizer Gaslightwala, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d11+27.27%-5.67%+1.53%-7.20%-4.88%—
14d11+45.45%-1.70%+2.04%-3.75%-4.64%—
30d11+54.55%+1.12%+3.61%-2.49%-4.46%—
60d11+0.00%-13.77%+4.18%-17.95%-21.80%—
90d11+0.00%-31.06%+4.25%-35.30%-40.01%—
180d11+36.36%-35.53%+10.12%-45.65%-80.32%—
1y11(7 pending)+0.00%-74.97%+24.04%-99.01%-99.06%—
2y11(11 pending)——————
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
AKTX · 5,500 shares · as of Jun 24, 2026
017,930,00035,860,00053,790,00071,720,00020252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2024
2025
2025
2025
2025
2026
2026
FLOW · 26 buys / 0 sellsCOVERAGE · 7 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
AKTX
AKARI THERAPEUTICS PLC
PURCHASEGRANT
Stock grant
5,500——5,500Jun 24, 2026Jun 25, 2026 ↗View →
AKTX
AKARI THERAPEUTICS PLC
PURCHASEGRANT
Stock grant
15,563——15,563Jun 24, 2026Jun 25, 2026 ↗View →
AKTX
AKARI THERAPEUTICS PLC
PURCHASE
CEO
773,323——773,323Dec 16, 2025Dec 18, 2025 ↗View →
AKTX
AKARI THERAPEUTICS PLC
PURCHASE
CEO
309,328——309,328Dec 16, 2025Dec 18, 2025 ↗View →
AKTX
AKARI THERAPEUTICS PLC
PURCHASE
CEO
309,328$0.40$125.0K309,328Dec 16, 2025Dec 18, 2025 ↗View →
AKTX
AKARI THERAPEUTICS PLC
PURCHASE
CEO
773,323$0.40$312.5K773,323Dec 16, 2025Dec 18, 2025 ↗View →
AKTX
AKARI THERAPEUTICS PLC
PURCHASE
CEO
3,000$0.90$2.7K298,574Aug 25, 2025Aug 29, 2025 ↗View →
AKTX
AKARI THERAPEUTICS PLC
PURCHASE
CEO
8,000$0.93$7.4K295,574Aug 22, 2025Aug 29, 2025 ↗View →
AKTX
AKARI THERAPEUTICS PLC
PURCHASE
CEO
10,000$0.94$9.4K287,574Aug 21, 2025Aug 29, 2025 ↗View →
AKTX
AKARI THERAPEUTICS PLC
PURCHASE
President & CEO
5,203$1.16$6.0K277,574Jun 24, 2025Jun 25, 2025 ↗View →
AKTX
AKARI THERAPEUTICS PLC
PURCHASE
President & CEO
943$1.15$1.1K272,371Jun 23, 2025Jun 25, 2025 ↗View →
AKTX
AKARI THERAPEUTICS PLC
PURCHASE
President & CEO
10,000$1.20$12.0K271,428Jun 20, 2025Jun 24, 2025 ↗View →
AKTX
AKARI THERAPEUTICS PLC
PURCHASE
President & CEO
15,000$1.20$18.0K261,428Jun 17, 2025Jun 20, 2025 ↗View →
AKTX
AKARI THERAPEUTICS PLC
PURCHASEGRANT
Stock grant
25,000$1.19$29.8K246,428Jun 13, 2025Jun 16, 2025 ↗View →
AKTX
AKARI THERAPEUTICS PLC
PURCHASEGRANT
Stock grant
20,000$1.23$24.6K221,428Jun 12, 2025Jun 16, 2025 ↗View →
AKTX
AKARI THERAPEUTICS PLC
PURCHASEGRANT
Stock grant
20,000$1.27$25.4K201,428Jun 10, 2025Jun 12, 2025 ↗View →
AKTX
AKARI THERAPEUTICS PLC
PURCHASEGRANT
Stock grant
1,100,000——1,100,000Mar 20, 2025Mar 24, 2025 ↗View →
AKTX
AKARI THERAPEUTICS PLC
PURCHASEGRANT
Stock grant
600,000——600,000Mar 20, 2025Mar 24, 2025 ↗View →
AKTX
AKARI THERAPEUTICS PLC
PURCHASEGRANT
Stock grant
133,928$1.12$150.0K133,928Mar 6, 2025Mar 10, 2025 ↗View →
AKTX
AKARI THERAPEUTICS PLC
PURCHASEGRANT
Stock grant
133,928$1.12$150.0K133,928Mar 6, 2025Mar 10, 2025 ↗View →
AKTX
AKARI THERAPEUTICS PLC
PURCHASEGRANT
Stock grant
133,928$1.12$150.0K181,428Mar 6, 2025Mar 10, 2025 ↗View →
AKTX
AKARI THERAPEUTICS PLC
PURCHASEGRANT
Stock grant
11,640$1.22$14.2K47,500Jan 10, 2025Feb 7, 2025 ↗View →
AKTX
AKARI THERAPEUTICS PLC
PURCHASEGRANT
Stock grant
11,439$1.22$14.0K35,860Jan 10, 2025Jan 13, 2025 ↗View →
AKTX
AKARI THERAPEUTICS PLC
PURCHASEGRANT
Stock grant
1,720,000$0.00$1.0K71,720,000Jan 3, 2025Jan 7, 2025 ↗View →
AKTX
AKARI THERAPEUTICS PLC
PURCHASEGRANT
Stock grant
40,000,000$0.00$20.0K70,000,000Dec 27, 2024Dec 30, 2024 ↗View →
AKTX
AKARI THERAPEUTICS PLC
PURCHASEGRANT
Stock grant
30,000,000$0.00$15.0K30,000,000Dec 26, 2024Dec 27, 2024 ↗View →
Other insiders · AKTX
Loading peer insiders…
About this filer
CIK 0002049375
ROLE
CEO
PRIMARY
AKTX
COMPANIES
1
ACTIVE SINCE
Dec 2024
MARKETPEEL · /INSIDER/0002049375DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback